Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Novel Treatments Using Pd1 Inhibitors for Advanced and Metastatic Cutaneous Squamous Cell Carcinoma Publisher Pubmed



Pezeshki S1, 2 ; Hemmati S1, 2 ; Rezaei N3, 4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Immunology Project Interest Group (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  2. 2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Expert Review of Anticancer Therapy Published:2020


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Tumor Immunology, Clinical Immunology (2022)
2. Review of the Recent Clinical Trials for Pd-1/Pd-L1 Based Lung Cancer Immunotherapy, Expert Review of Anticancer Therapy (2021)
3. Current and Future Perspectives of Pd-1/Pdl-1 Blockade in Cancer Immunotherapy, Journal of Immunology Research (2021)
4. Immune Checkpoint Inhibitor (Ici) Therapy in Central Nervous System Cancers: State-Of-The-Art and Future Outlook, International Immunopharmacology (2025)
5. Tumor Immunotherapies by Immune Checkpoint Inhibitors (Icis); the Pros and Cons, Cell Communication and Signaling (2022)
6. Immunotherapeutic Targets in Non-Small Cell Lung Cancer, Immunology (2023)
7. Biomarkers for Predicting the Outcome of Various Cancer Immunotherapies, Critical Reviews in Oncology/Hematology (2021)
8. Resistance to Immunotherapy in Human Malignancies: Mechanisms, Research Progresses, Challenges, and Opportunities, Journal of Cellular Physiology (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (12)
Hamid Reza Mirzaei (1)
Other Related Docs
9. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
10. Understanding the Tumor Microenvironment for Effective Immunotherapy, Medicinal Research Reviews (2021)
11. Immune Checkpoint Inhibitors in Cancer Therapy, Current Oncology (2022)
12. Pd-1/Pd-L1 Blockade: Prospectives for Immunotherapy in Cancer and Autoimmunity, IUBMB Life (2021)
13. Resistance Mechanisms to Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Inhibitors, Expert Opinion on Biological Therapy (2021)
14. Pd-1/Pd-L1 Pathway: Basic Biology and Role in Cancer Immunotherapy, Journal of Cellular Physiology (2019)
15. Pd-1/Pd-L and Autoimmunity: A Growing Relationship, Cellular Immunology (2016)
16. Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care, Cancer Genetics and Psychotherapy (2017)
17. Impact of Helicobacter Pylori Infection on the Efficacy of Immune Checkpoint Inhibitors for Cancer Treatment: A Meta-Analysis, Immunotherapy (2023)
18. The Evolving Landscape of Predictive Biomarkers in Immuno-Oncology With a Focus on Spatial Technologies, Clinical and Translational Immunology (2020)
19. Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer: From Immunological Mechanisms to Clinical Evidence, International Immunopharmacology (2021)
20. Immune Checkpoint Inhibitors: Review of the Existing Evidence and Challenges in Breast Cancer, Immunotherapy (2021)
21. Targets for Improving Tumor Response to Radiotherapy, International Immunopharmacology (2019)
22. Quantitative Evaluation of Abscopal Effect Based on Biological Effective Dose in Breast Cancer Tumors in Mice, International Journal of Radiation Research (2018)
23. Biomarkers for Immune Checkpoint Inhibitors, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)